{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:03:31Z","timestamp":1762506211474,"version":"3.38.0"},"reference-count":112,"publisher":"JLE","issue":"7","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.nephro.2013.10.002","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T10:45:47Z","timestamp":1383993947000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glom\u00e9rulopathie extramembraneuse"],"prefix":"10.1684","volume":"9","author":[{"given":"Lucile","family":"Mercadal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2013.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.V981389","article-title":"Mechanisms of progressive glomerular injury in membranous nephropathy","volume":"9","author":"Squarer","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0010","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.V7122518","article-title":"Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann Nephritis)","volume":"7","author":"Kerjaschki","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0015","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1681\/ASN.V9101759","article-title":"Megalin is an endocytic receptor for insulin","volume":"9","author":"Orlando","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1681\/ASN.V991638","article-title":"All four putatives ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis","volume":"9","author":"Yamazaki","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V6135","article-title":"The Heymann nephritis antigenic complex: megalin (gp 330) and RAP","volume":"6","author":"Farquhar","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1681\/ASN.V112191","article-title":"Receptor-associated protein is important for normal processing of megalin in kidney proximal tubules","volume":"11","author":"Birn","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000188225","article-title":"Immunohistochemical studies of votronectin. C5b-9\u00a0and vitronectin receptor in membranous nephropathy","volume":"68","author":"Ogawa","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2013.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1046\/j.1523-1755.2000.00950.x","article-title":"New insights into the pathogenesis of membranous nephropathy","volume":"57","author":"Shankland","year":"2000","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.nephro.2013.10.002_bib0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2012.426","article-title":"Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy","volume":"83","author":"Sendeyo","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2\u00a0receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000212068","article-title":"In search of the elusive membranous nephropathy antigen","volume":"112","author":"Salant","year":"2009","journal-title":"Nephron Physiol"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2\u00a0receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.nephro.2013.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","article-title":"Absence of glomerular IgG4\u00a0deposition in patients with membranous nephropathy may indicate malignancy","volume":"27","author":"Qu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.nephro.2013.10.002_bib0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2\u00a0receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.nephro.2013.10.002_bib0075","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.nephro.2013.10.002_bib0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.nephro.2013.10.002_bib0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2012070730","article-title":"Phospholipase A2\u00a0receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy","volume":"24","author":"Coenen","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.nephro.2013.10.002_bib0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1\u00a0and PLA(2)R1\u00a0alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.nephro.2013.10.002_bib0095","first-page":"64","article-title":"Secondary membranous glomerulonephritis","author":"Glassock","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.nephro.2013.10.002_bib0100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1681\/ASN.V84664","article-title":"Membranous glomerulonephritis","volume":"8","author":"Wasserstein","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2013.10.002_bib0105","first-page":"142","article-title":"Hepatitis B virus associated membranous glomerulonephritis in children\u2013experience in Hong Kong","volume":"40","author":"Wong","year":"1993","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.1989.307","article-title":"Membranous nephropathy in 52\u00a0hepatitis B surface antigen carrier children in Taiwan","volume":"36","author":"Hsu","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0115","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1046\/j.1523-1755.1999.00467.x","article-title":"HBV and proteinuria in relatives and contacts of children with hepatitis B virus-associated membranous nephropathy","volume":"55","author":"Bhimma","year":"1999","journal-title":"Kidney Int"},{"issue":"21","key":"10.1016\/j.nephro.2013.10.002_bib0120","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nephro.2013.10.002_bib0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/adc.88.5.446","article-title":"HBV associated nephrotic syndrome: resolution with oral lamivudine","volume":"88","author":"Connor","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nephro.2013.10.002_bib0130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/15.7.1097","article-title":"Membranous nephropathy with nephrotic syndrome in a HIV positive patient-remarkable remission with triple therapy","volume":"15","author":"Alarcon-Zurita","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2013.10.002_bib0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0272-6386(97)90573-4","article-title":"AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone","volume":"30","author":"Mattana","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.1996.03540060042033","article-title":"Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs","volume":"276","author":"Radford","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2013.10.002_bib0145","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/ndt\/16.11.2253","article-title":"Membranous nephropathy from exposure to mercury in the fluorescent-tube-recycling industry","volume":"16","author":"Aymaz","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2013.10.002_bib0150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/ajkd.2003.50017","article-title":"A whitened face woman with nephrotic syndrome","volume":"41","author":"Soo","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0155","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-120-5-199403010-00007","article-title":"Membranous nephropathy and formaldehyde exposure","volume":"120","author":"Breysse","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0160","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/ndt\/17.10.1771","article-title":"Factors affecting outcome and prognosis in membranous nephropathy","volume":"17","author":"Mercadal","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.1983.170","article-title":"Pathologic differenciation between lupus and nonlupus membranous glomerulopathy","volume":"24","author":"Jennette","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00005792-197711000-00007","article-title":"Membranous lupus nephropathy: a clinicopathologic study","volume":"56","author":"Donadio","year":"1977","journal-title":"Medicine"},{"key":"10.1016\/j.nephro.2013.10.002_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bmj.1.6052.25","article-title":"Pathogenesis of membranous nephropathy in systemic lupus erythematosus: possible role of non precipitating DNA antibody","volume":"1","author":"Friend","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.nephro.2013.10.002_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000187758","article-title":"Membranous nephropathy associated with hypocomplementemic urticarial vasculitis: report of two cases and review of the literature","volume":"66","author":"Kobayashi","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2013.10.002_bib0185","first-page":"645","article-title":"Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin","volume":"4","author":"Weigle","year":"1969","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0190","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJM198105143042006","article-title":"Studies of immune-complex glomerulonephritis mediated by human thyroglobulin","volume":"304","author":"Jordan","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1530\/acta.0.1090341","article-title":"Proteinuria in autoimmune thyroid disease","volume":"109","author":"Weetman","year":"1985","journal-title":"Acta Endocrinol"},{"issue":"2","key":"10.1016\/j.nephro.2013.10.002_bib0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0272-6386(99)70314-8","article-title":"Membranous glomerulonephritis associated with Graves\u2019 disease","volume":"33","author":"Becker","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0205","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ndt\/gfh615","article-title":"Groupe d\u2019\u00e9tudes des n\u00e9phropathies associ\u00e9es aux thymomes","volume":"20","author":"Karras","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.nephro.2013.10.002_bib0210","first-page":"154","article-title":"Analysis of renal pathology and drug history in 158\u00a0Japanese patients with rheumatoid arthritis","volume":"50","author":"Nakano","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/13.7.1815","article-title":"Pulmonary haemorrhage in a patient with idiopathic membranous nephropathy","volume":"13","author":"Dienstl","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0220","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/oxfordjournals.ndt.a027416","article-title":"Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine","volume":"11","author":"Mathieson","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0225","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ndt\/12.5.1017","article-title":"Association of vasculitis glomerulonephritis with membranous nephropathy: a report of 10\u00a0cases","volume":"12","author":"Tse","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.nephro.2013.10.002_bib0230","first-page":"253","article-title":"Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulopathy","volume":"52","author":"Taniguchi","year":"1999","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.nephro.2013.10.002_bib0235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.04060808","article-title":"Membranous glomerulonephrtis with ANCA-associated necrotizing and crescentic glomerulonephritis","volume":"4","author":"Nasr","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.nephro.2013.10.002_bib0240","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1681\/ASN.2010090923","article-title":"Membranous nephropathy with crescents","volume":"22","author":"Basford","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0245","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0272-6386(98)70085-X","article-title":"Childhood membranous nephropathy, circulating antibodies to the 58-kd TIN antigen, and antitubular basement membrane nephritis: an 11-year follow-up","volume":"32","author":"Ivanyi","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0250","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.nephro.2013.10.002_bib0255","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0260","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/bmj.289.6457.1500","article-title":"Familial membranous nephropathy","volume":"289","author":"Short","year":"1984","journal-title":"Brit Med J"},{"issue":"1","key":"10.1016\/j.nephro.2013.10.002_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0272-6386(97)90017-2","article-title":"Idiopathic membranous nephropathy in identical twins","volume":"29","author":"Guella","year":"1997","journal-title":"Am J Kidney J"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0270","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0272-6386(12)80132-6","article-title":"HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3\u00a0associations with progressive renal injury","volume":"23","author":"Freedman","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.nephro.2013.10.002_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.1998.v31.pm9428445","article-title":"Prognostic factors in idiopathic membranous nephropathy","volume":"31","author":"Reichert","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with membranous nephropathy","volume":"329","author":"Schieppati","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0285","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ki.1992.374","article-title":"Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis","volume":"42","author":"Pei","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0290","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1997.127","article-title":"Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications","volume":"51","author":"Cattran","year":"1997","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.nephro.2013.10.002_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.1998.v31.pm9428445","article-title":"Prognostic factors in idiopathic membranous nephropathy","volume":"31","author":"Reichert","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0300","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2005.08.020","article-title":"Idiopathic membranous nephropathy: outline and rationale of a treatment strategy","volume":"46","author":"Du Buf-Vereijken","year":"2005","journal-title":"Am J kidney Dis"},{"issue":"8","key":"10.1016\/j.nephro.2013.10.002_bib0305","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.00670112","article-title":"Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy","volume":"7","author":"van den Brand","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2013.10.002_bib0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0272-6386(00)70190-9","article-title":"ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome","volume":"35","author":"Ruggenenti","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0315","first-page":"25","article-title":"Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult with idiopathic membranous nephropathy: a prospective study of long-term treatment","volume":"10","author":"Rostoker","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0320","unstructured":"Gansevoort R, Heeg JE, Vriesendorp R, Zeeuw D, de Jon PE. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy. Nephrol Dial Transplant 1992;(Suppl. 1): 91\u20136."},{"issue":"suppl 1","key":"10.1016\/j.nephro.2013.10.002_bib0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000186044","article-title":"Enalapril improved renal function and proteinuria in chronic glomerulonephritis","volume":"55","author":"Ferder","year":"1990","journal-title":"Nephron"},{"issue":"12","key":"10.1016\/j.nephro.2013.10.002_bib0330","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/12.12.2576","article-title":"Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9\u00a0urinary excretion in membranous nephropathy","volume":"12","author":"Praga","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.nephro.2013.10.002_bib0335","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.ajkd.2008.03.008","article-title":"Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression","volume":"52","author":"Catapano","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0340","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10157-009-0130-5","article-title":"Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy","volume":"13","author":"Gupta","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0345","first-page":"219","article-title":"A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatine and diet versus diet alone","volume":"46","author":"Rayner","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0350","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.1994.75","article-title":"Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy","volume":"45","author":"Sarasin","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0355","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","article-title":"Lamivudine in hepatitis B-associated membranous nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0360","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"Hogan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0365","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.V581553","article-title":"Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials","volume":"5","author":"Imperiale","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0370","first-page":"CD004293","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome","volume":"4","author":"Schieppati","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2013.10.002_bib0375","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0380","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.nephro.2013.10.002_bib0385","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0272-6386(99)70050-8","article-title":"Treatment and long-term follow-up of patients with stage II and III idiopathic membranous nephropathy","volume":"34","author":"Polenakovik","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/qjmed\/91.2.159","article-title":"Immunosuppression and outcome in idiopathic membranous nephropathy","volume":"91","author":"Stirling","year":"1998","journal-title":"Q J Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0395","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-121-5-199409010-00003","article-title":"Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide","volume":"121","author":"Reichert","year":"1994","journal-title":"Ann Med Intern"},{"key":"10.1016\/j.nephro.2013.10.002_bib0400","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/91.5.359","article-title":"Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency","volume":"91","author":"Branten","year":"1998","journal-title":"Q J Med"},{"key":"10.1016\/j.nephro.2013.10.002_bib0405","first-page":"1","article-title":"Short and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency","volume":"56","author":"Branten","year":"2001","journal-title":"Clin Nephrol"},{"issue":"suppl 61","key":"10.1016\/j.nephro.2013.10.002_bib0410","first-page":"63","article-title":"Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency","volume":"52","author":"Wetzels","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0415","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1523-1755.2002.00124.x","article-title":"Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy","volume":"61","author":"Torres","year":"2002","journal-title":"Kidney Int"},{"issue":"9868","key":"10.1016\/j.nephro.2013.10.002_bib0420","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","article-title":"Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial","volume":"381","author":"Howman","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2013.10.002_bib0425","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.2.5756.239","article-title":"Controlled trial of azathioprine and prednisone in chronic renal disease","volume":"267","author":"Medical research Council Working Party","year":"1971","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2013.10.002_bib0430","first-page":"1209","article-title":"Controlled trial of azathioprine in the nephrotic syndrome secondary to membranous nephropathy","volume":"115","author":"Western Canadian Glomerulonephritis Study Group","year":"1976","journal-title":"Can Med Assoc J"},{"issue":"3","key":"10.1016\/j.nephro.2013.10.002_bib0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0272-6386(99)70081-8","article-title":"Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?","volume":"34","author":"Ahuja","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0440","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/oxfordjournals.ndt.a027844","article-title":"Treatment of the renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone","volume":"13","author":"Brown","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0445","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","article-title":"Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2\u00a0cytokine inhibition","volume":"9","author":"Penny","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.nephro.2013.10.002_bib0450","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/ajkd.2000.8968","article-title":"Use of mycophenolate mofetil in resistant membranous nephropathy","volume":"36","author":"Miller","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0455","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ndt\/gfg113","article-title":"Mycophenolate mofetil in the treatment of idiopathic stages III-IV membranous nephropathy","volume":"18","author":"Polenakovic","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0460","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ndt\/gfm538","article-title":"Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study","volume":"23","author":"Nayagam","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.nephro.2013.10.002_bib0465","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1440-1797.2007.00822.x","article-title":"Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome","volume":"12","author":"Chan","year":"2007","journal-title":"Nephrology"},{"issue":"4","key":"10.1016\/j.nephro.2013.10.002_bib0470","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.ajkd.2008.04.013","article-title":"Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial","volume":"52","author":"Dussol","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.nephro.2013.10.002_bib0475","first-page":"67","article-title":"A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy","volume":"52","author":"Boumpas","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0480","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1523-1755.1999.00675.x","article-title":"Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephroapthy","volume":"56","author":"Berg","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0485","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5414\/CNP62403","article-title":"ACTH therapy in nephrotic syndrome induced by idiopathic membranous nephropathy","volume":"62","author":"Picardi","year":"2004","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.nephro.2013.10.002_bib0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy","volume":"47","author":"Ponticelli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2013.10.002_bib0495","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0500","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0505","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/ndt\/gfl360","article-title":"Induction and long term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome","volume":"21","author":"Alexopoulos","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0510","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0515","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/ndt\/gfm366","article-title":"Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophnolate mofetil: result of a pilot study","volume":"22","author":"Ballarin","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.nephro.2013.10.002_bib0520","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","article-title":"Rituximab in idiopathic membranous nephropathy: a one-year prospective study","volume":"14","author":"Ruggenenti","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.nephro.2013.10.002_bib0525","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1681\/ASN.2012020181","article-title":"Rituximab in idiopathic membranous nephropathy","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0530","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.ki.5002628","article-title":"Rituximab treatment of idiopathic membranous nephropathy","volume":"73","author":"Fervenza","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.10.002_bib0535","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.01180307","article-title":"Titrating rituxiamb to circulating B celles to optimize lymphocytolytic therapy in idiopathic membranous nephropathy","volume":"2","author":"Cravedi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0540","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2215\/CJN.06041108","article-title":"Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients","volume":"4","author":"Segarra","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2013.10.002_bib0545","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/ndt\/14.10.2379","article-title":"The short and long term outcomes of membranous nephropathy treated with intravenous immune globulin therapy","volume":"14","author":"Yokoyama","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2013.10.002_bib0550","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrneph.2009.14","article-title":"Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma","volume":"5","author":"Mok","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.nephro.2013.10.002_bib0555","first-page":"186","article-title":"Kidney Disease\u2013Improving Glocal Outcomes (KDIGO) clinical practice guideline for glomerulonephritis. Chapter 7: idiopathic membranous nephropathy","author":"International Society of Nephrology","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.nephro.2013.10.002_bib0560","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000327611","article-title":"Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study","volume":"33","author":"Cravedi","year":"2011","journal-title":"Am J Nephrol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972551300552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972551300552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2013.10.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:53:46Z","timestamp":1741186426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972551300552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":112,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S176972551300552X"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2013.10.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glom\u00e9rulopathie extramembraneuse","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2013.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}